Morning Consult Health Presented by the Alzheimer’s Association: CVS Closing In on Deal to Acquire Oak Street Health, per Report




 


Health

Essential health care industry news & intel to start your day.
February 7, 2023
Twitter Email
 

Today’s Top News

  • CVS Health Corp. is nearing a deal to acquire Oak Street Health Inc. for about $10.5 billion including debt, with an announcement possibly as soon as this week, people with knowledge of the matter said. The deal would expand CVS’s presence in primary care and add to last year’s $8 billion pickup of home care provider Signify Health Inc. (The Wall Street Journal)
  • President Joe Biden’s State of the Union address will include calls for private insurers to cap patients’ insulin costs and to close the Medicaid coverage gap in Republican-controlled states if they have not yet expanded the program under the Affordable Care Act. Neither proposal has a strong chance of being enacted. (Axios)
  • A bipartisan group of senators sent letters to Monument Inc., Workit Health Inc. and Cerebral Inc., taking the three telehealth providers to task for sharing patients’ health information with Meta Platforms Inc.’s Facebook and Alphabet Inc.’s Google, among other major advertising platforms. Sens. Amy Klobuchar (D-Minn.), Susan Collins (R-Maine), Maria Cantwell (D-Wash.) and Cynthia Lummis (R-Wyo.) requested information on data-sharing practices and warned that sharing information could lead to patients being targeted by advertisements for services that “may be unnecessary or potentially harmful physically, psychologically, or emotionally.” (Stat News)
  • Senate Finance Committee Chairman Ron Wyden (D-Ore.) vowed that Democrats intend to protect Medicare drug price negotiation measures passed last year as part of the Inflation Reduction Act and that the pharmaceutical industry is targeting. Wyden said during an event that pharmaceutical companies are attempting to “water down” certain consumer protections , but he said Democrats are not interested in changing any provisions. (Fierce Healthcare)

Worth watching today:

 

Chart Review



 
 

What Else You Need to Know

Coronavirus
 

It’s Too Soon for Annual Covid Booster Shots, Some Experts Say

Celine Castronuovo, Bloomberg Law

It’s too early to tell if the US population will need annual Covid-19 booster shots, infectious disease doctors say. They say they don’t yet know how best to respond to the unpredictable patterns of new variants. But a “regular cadence” of annual Covid-19 shots in line with flu shots would “get more people to get into a rhythm of keeping up to date,” Anthony S. Fauci, President Joe Biden’s former chief medical adviser, said in an interview.

 

A new COVID-19 subvariant is a growing concern for experts. Here’s why

Frank Diamond, Fierce Healthcare

The sighting and monitoring of any new COVID-19 variant — this time it’s CH.1.1 — must be given context, experts say.

 

Lawyers for U.S., Navy Seals battle over revoked Covid-19 vaccine mandate

Josh Gerstein, Politico

A lawyer representing Navy Seals who do not want to be vaccinated against Covid-19 told a federal appeals court Monday that their lawsuit over a now-withdrawn vaccine mandate isn’t moot even though Congress passed legislation last December ordering the policy canceled.

 

Healthy lifestyle may mean lower risk of long Covid, study says

Katherine Dillinger, CNN

People who have a healthy lifestyle before Covid-19 infection may have a lower risk of long Covid than their peers, a new study says. The study, published Monday in JAMA Internal Medicine, looked at almost 2,000 women who reported a positive Covid-19 test between April 2020 and November 2021.

 

New York City drops COVID-19 vaccine requirement for city workers

Erin Doherty, Axios

New York City Mayor Eric Adams (D) announced Monday that he is lifting the COVID-19 vaccine mandate for current and prospective city workers starting Friday.

 

A Secret Weapon in Preventing the Next Pandemic: Fruit Bats

Jim Robbins, Kaiser Health News

More than four dozen Jamaican fruit bats destined for a lab in Bozeman, Montana, are set to become part of an experiment with an ambitious goal: predicting the next global pandemic.

 

Patient’s race and method of dialysis are linked to higher risk of blood infection

Isabella Cueto, Stat News

Hispanic, Latino, and non-Hispanic Black Americans on dialysis for end-stage kidney disease have a higher risk of developing life-threatening bloodstream infections, a new report says. And those racial and ethnic disparities are deepened by another risk factor: how the patient received hemodialysis.

 

Former Sen. Richard Burr to join health care practice at law and lobbying firm

Rachel Cohrs, Stat News

Former Sen. Richard Burr is the latest participant in Washington’s revolving door between Congress and industry. Burr, who was the lead Republican on the Senate health committee until his retirement in January, will be starting as a senior policy adviser and chair of a new health policy strategic consulting practice at DLA Piper, the firm announced Tuesday.

 

Judge suggests abortion might be protected by 13th Amendment despite Supreme Court ruling

Dan Mangan, CNBC

Judge Colleen Kollar-Kotelly posed that eyebrow-raising hypothetical in a court order in a criminal case against a group of anti-abortion activists charged with blocking access to an abortion clinic in Washington, D.C.

 

Private equity notched second-highest year of healthcare dealmaking in 2022, Pitchbook finds

Rebecca Pifer, Healthcare Dive

PE firms announced or closed an estimated 863 deals in 2022, making last year the second-highest on record for activity in the sector, after 2021, according to a new report from market data firm Pitchbook.

 

The ADHD medication shortage is getting worse. What went wrong?

Caroline Hopkins, NBC News

As the nationwide Adderall shortage enters its fifth month, people who rely on medication to help manage attention-deficit/hyperactivity disorder are finding few, if any, available alternatives.

 

Heart defect diagnosis often comes too late – or not at all – for Latino infants, study finds

Nada Hassanein, USA Today

Infants born to Latino, low-income or limited-English speaking parents are more likely to be diagnosed later with congenital heart disease than white infants – or lack a prenatal diagnosis at all, a new study found.

 

What Doctors Are Learning About Marijuana and Surgery

Sumathi Reddy, The Wall Street Journal

As more states allow people to smoke pot and eat edibles legally, more doctors say they are asking about marijuana use—and urging honesty—before surgeries or procedures because habitual users may need more anesthesia and painkillers. In one study, people who reported they used cannabis required more anesthesia than people who didn’t use it.

 

Hundreds of food products recalled due to Listeria concerns

Lauren Sforza, The Hill

The Fresh Ideation Group, which is based in Baltimore, Md., is recalling food products sold from Jan. 24 through Jan. 30, according to an announcement released by the FDA.

 

The U.K.’s Government-Run Healthcare Service Is in Crisis

David Luhnow and Max Colchester, The Wall Street Journal

Ill children turned away from hospitals. Three-day-long emergency room waits. Nurses on strike. The NHS is struggling under the effects of budget cuts, Covid delays and an aging population.

 
General
 

Patient’s race and method of dialysis are linked to higher risk of blood infection

Isabella Cueto, Stat News

Hispanic, Latino, and non-Hispanic Black Americans on dialysis for end-stage kidney disease have a higher risk of developing life-threatening bloodstream infections, a new report says. And those racial and ethnic disparities are deepened by another risk factor: how the patient received hemodialysis.

 

Former Sen. Richard Burr to join health care practice at law and lobbying firm

Rachel Cohrs, Stat News

Former Sen. Richard Burr is the latest participant in Washington’s revolving door between Congress and industry. Burr, who was the lead Republican on the Senate health committee until his retirement in January, will be starting as a senior policy adviser and chair of a new health policy strategic consulting practice at DLA Piper, the firm announced Tuesday.

 

Judge suggests abortion might be protected by 13th Amendment despite Supreme Court ruling

Dan Mangan, CNBC

Judge Colleen Kollar-Kotelly posed that eyebrow-raising hypothetical in a court order in a criminal case against a group of anti-abortion activists charged with blocking access to an abortion clinic in Washington, D.C.

 

Private equity notched second-highest year of healthcare dealmaking in 2022, Pitchbook finds

Rebecca Pifer, Healthcare Dive

PE firms announced or closed an estimated 863 deals in 2022, making last year the second-highest on record for activity in the sector, after 2021, according to a new report from market data firm Pitchbook.

 

The ADHD medication shortage is getting worse. What went wrong?

Caroline Hopkins, NBC News

As the nationwide Adderall shortage enters its fifth month, people who rely on medication to help manage attention-deficit/hyperactivity disorder are finding few, if any, available alternatives.

 

Heart defect diagnosis often comes too late – or not at all – for Latino infants, study finds

Nada Hassanein, USA Today

Infants born to Latino, low-income or limited-English speaking parents are more likely to be diagnosed later with congenital heart disease than white infants – or lack a prenatal diagnosis at all, a new study found.

 

What Doctors Are Learning About Marijuana and Surgery

Sumathi Reddy, The Wall Street Journal

As more states allow people to smoke pot and eat edibles legally, more doctors say they are asking about marijuana use—and urging honesty—before surgeries or procedures because habitual users may need more anesthesia and painkillers. In one study, people who reported they used cannabis required more anesthesia than people who didn’t use it.

 

Hundreds of food products recalled due to Listeria concerns

Lauren Sforza, The Hill

The Fresh Ideation Group, which is based in Baltimore, Md., is recalling food products sold from Jan. 24 through Jan. 30, according to an announcement released by the FDA.

 

The U.K.’s Government-Run Healthcare Service Is in Crisis

David Luhnow and Max Colchester, The Wall Street Journal

Ill children turned away from hospitals. Three-day-long emergency room waits. Nurses on strike. The NHS is struggling under the effects of budget cuts, Covid delays and an aging population.

 
Payers
 

The Medicine Is a Miracle, but Only if You Can Afford It

Gina Kolata and Francesca Paris, The New York Times

A wave of new treatments have cured devastating diseases. When the costs are too much, even for the insured, patients hunt for other ways to pay.

 

Arbitration Process of Surprise Medical Billing Rule Tossed

Janet Miranda, Bloomberg Law

A federal judge in Texas on Monday tossed out portions of a rule that established the arbitration process in the federal No Surprises Act, which is meant to shield patients from unanticipated medical bills.

 

CVS Health names new chief diversity, equity and inclusion officer

Paige Minemyer, Fierce Healthcare

Shari Slate will join the healthcare giant effective Feb. 27 as its new chief diversity, equity and inclusion officer. Slate will report to Chief People Officer Laurie Havanec. In the new role, Slate will be responsible for driving innovative solutions that ensure the company’s 300,000-strong workforce reflects the customers it serves, CVS said.

 
Providers
 

Decisions by CVS and Optum Panicked Thousands of Their Sickest Patients

Arthur Allen, Kaiser Health News

Pharmacy closures by two of the biggest home infusion companies point to grave shortages and dangers for patients who require IV nutrition to survive.

 

Virtual prescribing of controlled substances is in limbo as PHE winds down

Gabriel Perna and Brock E.W. Turner, Modern Healthcare

The coming end of the COVID-19 public health emergency and pandemic-era telehealth flexibilities could rattle an already besieged behavioral health system and force providers to make ethical decisions.

 

The virus threat is easing, but US hospitals are still as full as ever

Deidre McPhillips, CNN

Hospitals were facing capacity and resource challenges long before the pandemic hit, experts say, in large part because the people who are being admitted are sicker than they were before.

 
Pharma, Biotech and Devices
 

Boarding priority review track, Biogen and Sage get August decision date for depression drug approval

Nick Paul Taylor, Fierce Biotech

Add Aug. 5 to your diaries. That is the FDA’s decision date for the approval of Biogen and Sage Therapeutics’ zuranolone, which the agency has accepted for priority review as an oral treatment of major depressive disorder and postpartum depression.

 

Angry at Vertex pricing of cystic fibrosis drugs, families in four countries seek to override patents

Ed Silverman, Stat News

In a bid to expand access to pricey cystic fibrosis treatments, a coalition of families and activists are petitioning four governments — South Africa, India, Brazil, and Ukraine — to make it possible to obtain generic versions of a medicine sold by Vertex Pharmaceuticals. And the coordinated effort underscores the growing global battle over equal access to medicines.

 

J&J’s latest data for nipocalimab in fetal disorder suggests Momenta acquisition may still pay off

James Waldron, Fierce Biotech

When Johnson & Johnson acquired nipocalimab as part of the $6.5 billion takeover of Momenta Pharmaceuticals, the hype surrounding the therapy was focused on its potential as a treatment for the hot disease area of myasthenia gravis. But a top-line phase 2 readout for the drug in a fetal disorder is a reminder that nipocalimab could have a far broader reach.

 

DC appeals court revives case accusing pharmas of financing terror attacks

Paul Schloesser, Endpoints News

The case involves accusations against AstraZeneca, Pfizer, Roche, J&J and other pharma companies for financing terrorists who either injured or killed American citizens. The companies denied the allegations.

 

Abbott device approval sets up battle with Medtronic, Nevro for diabetic peripheral neuropathy treatment

Elise Reuter, MedTech Dive

Abbott’s Proclaim XR spinal cord stimulation device was first approved to treat chronic pain in 2019. The expanded approval now has it fighting for share with Nevro, which specializes in spinal cord stimulation, and Medtronic, one of the largest medical device makers by revenue.

 
Health Technology
 

How post-acute care facilities use technology to save time, fight burnout

Mari Devereaux, Modern Healthcare

The past several years have seen an increased demand for post-acute care services, particularly in the home. Faced with ongoing staffing shortages, providers like Vitas have turned to digital platforms for help.

 

Mm-hm, uh-huh: AI-powered medical scribes still can’t understand our conversations

Brittany Trang, Stat News

While medical providers are trying to decrease physician burnout by turning to tools sold by Microsoft and others to transcribe patient-provider conversations and write visit notes, a recent study found that speech-to-text engines meant to transcribe medical conversations do not accurately record clinically relevant “non-lexical conversational sounds,” or NLCS.

 

Tallahassee hospital continues to operate offline, working with FBI to address ‘IT security event’

Heather Landi, Fierce Healthcare

According to an update posted to its website Monday afternoon, the hospital is now performing “limited surgeries and procedures.” “Patients will be notified by TMH if they are scheduled for surgery and by their doctor’s office if they need to be rescheduled,” the hospital said. The hospital is still diverting some emergency room patients to other hospitals.

 







Morning Consult